InsidersTradesSigma
Track the Swedish Orphan Biovitrum AB (Sobi) stock price and the full management transaction log of the company, a listed equity based in Finland. Shares are listed on the FI market, under the supervision of FIN-FSA. Market capitalisation: €164.1bn. The full history is free.
Analysts rate Swedish Orphan Biovitrum AB (Sobi) Buy (bullish), based on 12 analysts. Average price target: SEK 498.83.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
Swedish Orphan Biovitrum AB (Sobi) is a Swedish biopharmaceutical company focused on developing treatments for rare diseases. It specializes in products for hematological disorders and genetic diseases.